In a mouse femur model where MC57G fibrosarcoma cells were injected to induce bone cancer, epigallocatechin gallate lessened the neuroinflammation and pain behavior caused by bone cancer through suppressing TNF-α expression in the spinal cord (Li and Zhang, 2015). Here, TNF is linked to bone neoplasm.